Ekkie Thump
Full Member
- Joined
- Mar 9, 2013
- Messages
- 4,359
- Supports
- Leeds United
Biologics should make in theory for very effective agents
The aetiology of the most severe manifestation of COVID19 is ARDS which is underpinned by cytokine storm so agents targeting that should definitely be considered in reducing mortality and morbidity
https://www.cancernetwork.com/news/...clinical-trial-tocilizumab-covid-19-pneumonia
Tocilizumab is another good shout
Yeah, this seems like a pretty good review (as of March 26th) of what avenues are being explored in this direction.
Cliff notes: There's hope, but it's way too soon to tell. JAK inhibitors (Baricitinib) and IL-6 blockers seem likeliest.